Q: Please comment on Stantec earnings. Which do you prefer STN to WSP at this point? Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Can you comment on Clearwater's results, the stock is down significantly today.
Thanks
Thanks
Q: I am looking for an ETF with a high percentage of sand and gravel [aggregate] companies. I don't think there is a specific ETF for aggregate companies but there are ETF's which include them. Could you also recommend the best aggregate company in the world?
Thank you.
Ross.
Thank you.
Ross.
Q: Can you please comment on RUS earnings?
Thank you
Thank you
Q: Hello Peter,
Is it correct to say that the time to buy cyclical stocks are around the peak of the cycle? Where do you see the auto sector in the cycle and would you recommend adding to stocks such as LNR/MG/XTC?
Also, if you heard the CEO on the conference call or BNN; is the intent to diversify into Agricultural equipment sector a show of bravado w.r.t nafta or is it a sign of full steam ahead ?
Regards
Is it correct to say that the time to buy cyclical stocks are around the peak of the cycle? Where do you see the auto sector in the cycle and would you recommend adding to stocks such as LNR/MG/XTC?
Also, if you heard the CEO on the conference call or BNN; is the intent to diversify into Agricultural equipment sector a show of bravado w.r.t nafta or is it a sign of full steam ahead ?
Regards
Q: Great new website, I would like your thoughts on OSB , intend to hold it for about 3-4 years.
-
Teck Resources Limited Class B Subordinate Voting Shares (TECK.B $54.58)
-
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA $18.38)
Q: Hi,
It seems that many of your members have noticed the decline in TEVA and are optmistic for its recovery. This situtation reminds me a bit of TECK from 2015. I never purchased TECK back in 2015 when it was sub $5 because you cautioned about its debt level. TECK has since gained to $27. Do you have more concerns about TEVA now than you did about TECK two years ago? There is certainly upside to TEVA, but a cheap stock can always get cheaper.
Even now, the short interest (according to my RBC account is less than 7%). Have the short sellers moved on from this one?
What is the probability of bankruptcy? If this isn't likely, how much worse can it really get?
It seems that many of your members have noticed the decline in TEVA and are optmistic for its recovery. This situtation reminds me a bit of TECK from 2015. I never purchased TECK back in 2015 when it was sub $5 because you cautioned about its debt level. TECK has since gained to $27. Do you have more concerns about TEVA now than you did about TECK two years ago? There is certainly upside to TEVA, but a cheap stock can always get cheaper.
Even now, the short interest (according to my RBC account is less than 7%). Have the short sellers moved on from this one?
What is the probability of bankruptcy? If this isn't likely, how much worse can it really get?
Q: Gentlemen.
I did not find the 5I all Covered companies list (summary)
Thanks
Best regards
I did not find the 5I all Covered companies list (summary)
Thanks
Best regards
Q: Please comment on the latest quarter. Buy, sell or hold? Can you suggest a same sector replacement with stronger momentum but pays a dividend? Thanks
Q: Why the adverse market reaction to NYX today?
Q: Hello
Can you comment on RME and KPT 3rd quarter earnings?
Also for RME can you give me the cash flow to debt ratio you often refer to?
Thank you
Stephane
Can you comment on RME and KPT 3rd quarter earnings?
Also for RME can you give me the cash flow to debt ratio you often refer to?
Thank you
Stephane
Q: Please comment on ALC's latest earnings. Revenue appears to be up but earnings lower possibly due to one time items which boosted earnings in 2016.
Thank you,
Jim
Thank you,
Jim
Q: Congrats on the new web site. Most definitely a big step in the right direction. Excellent work! Thank You. Greatly appreciated.
Few questions re web site or web site related.
I recently saw that somebody asked you for the consensus estimates for AVO. You stated "$0.22 EPS; $107.7M revenue".
- Looking at your web site (assuming I properly understand) it shows current estimate (and for last 2 months) "$0.20 EPS". Are you using the same source for your data? I am hoping to be in sync.
- Does the web site provide consensus numbers for Revenue, Net Income in addition to EPS?
- Side question. Analyst consensus numbers - are these #s based on the top line and bottom line numbers or "adjusted" top line and adjusted bottom line or "adjusted diluted".... or can it vary from one company to another (as I feel I have seen situations of the latter)?
When referencing the company section, are there restrictions to which companies you have in your database. I tried to access Amedisys (AMED on Nasdaq). No luck. Same challenge with CNI (on NYSE) but CNR present.
On multiple occasions there are questions pertaining to P/E in the Q&A. You always mention that you use forward looking P/E. Is the web site providing the forward P/E or other? Hoping to be in sync.
What is the update frequency for the "News and Media" section in the Company section?
Thank You!
Few questions re web site or web site related.
I recently saw that somebody asked you for the consensus estimates for AVO. You stated "$0.22 EPS; $107.7M revenue".
- Looking at your web site (assuming I properly understand) it shows current estimate (and for last 2 months) "$0.20 EPS". Are you using the same source for your data? I am hoping to be in sync.
- Does the web site provide consensus numbers for Revenue, Net Income in addition to EPS?
- Side question. Analyst consensus numbers - are these #s based on the top line and bottom line numbers or "adjusted" top line and adjusted bottom line or "adjusted diluted".... or can it vary from one company to another (as I feel I have seen situations of the latter)?
When referencing the company section, are there restrictions to which companies you have in your database. I tried to access Amedisys (AMED on Nasdaq). No luck. Same challenge with CNI (on NYSE) but CNR present.
On multiple occasions there are questions pertaining to P/E in the Q&A. You always mention that you use forward looking P/E. Is the web site providing the forward P/E or other? Hoping to be in sync.
What is the update frequency for the "News and Media" section in the Company section?
Thank You!
Q: What are your thoughts on LNR earings?
I currently hold 2% - Should I buy more, Sell or hold.
Thanks for the great service
I currently hold 2% - Should I buy more, Sell or hold.
Thanks for the great service
Q: are you pleased with the results of avo. would you buy qst at this time.
thanks donald
thanks donald
Q: Can you please comment on the earnings for $TIH. Thanks Valter
Q: I purchased ITP in Sep 2016 just below $23. It has been a "rocky road" since then, especially sine late July of this year. I hold about a 6% position in a reasonable well diversified RRSP account. I am looking to continue this RRSP for another 5 years or so. I suppose I am looking for some reassurance that the company will still be in business by the time I divest. I would appreciate your thoughts about the company over the next 5 years or so (as much as that is possible for anyone to provide). Thank you.
Q: What do think of a switch from SJ to OSB? The US homebuilding seems to be on an upward trend...
Q: I am a big supporter of your service but I am a little disappointed that the initial page I seen when I sign in is only showing the US markets and US movers. I know the NYSE is the most important market in the world and is a major influence on our Canada markets. However, I thought most of us bought into to this as a service for Canadian stocks. Especially in Canada with the dividend tax credit that is the primary focus of many Canadian investors. I think the US information is useful but should be a supplement for more detailed Canadian stock information e.g. movers by Canadian income and growth stocks.
mike
mike
Q: Hi, would like your thoughts on Stelio. Thank you.